1. Home
  2. NURO vs LCFY Comparison

NURO vs LCFY Comparison

Compare NURO & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • LCFY
  • Stock Information
  • Founded
  • NURO 1996
  • LCFY 2009
  • Country
  • NURO United States
  • LCFY Australia
  • Employees
  • NURO N/A
  • LCFY N/A
  • Industry
  • NURO Medical/Dental Instruments
  • LCFY
  • Sector
  • NURO Health Care
  • LCFY
  • Exchange
  • NURO Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • NURO 8.2M
  • LCFY 7.3M
  • IPO Year
  • NURO N/A
  • LCFY 2022
  • Fundamental
  • Price
  • NURO $4.37
  • LCFY $7.26
  • Analyst Decision
  • NURO
  • LCFY
  • Analyst Count
  • NURO 0
  • LCFY 0
  • Target Price
  • NURO N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • NURO 21.7K
  • LCFY 24.4K
  • Earning Date
  • NURO 02-20-2025
  • LCFY 04-01-2025
  • Dividend Yield
  • NURO N/A
  • LCFY N/A
  • EPS Growth
  • NURO N/A
  • LCFY N/A
  • EPS
  • NURO N/A
  • LCFY N/A
  • Revenue
  • NURO $3,767,764.00
  • LCFY $2,668,385.00
  • Revenue This Year
  • NURO N/A
  • LCFY N/A
  • Revenue Next Year
  • NURO N/A
  • LCFY N/A
  • P/E Ratio
  • NURO N/A
  • LCFY N/A
  • Revenue Growth
  • NURO N/A
  • LCFY N/A
  • 52 Week Low
  • NURO $2.66
  • LCFY $2.20
  • 52 Week High
  • NURO $4.73
  • LCFY $11.23
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.97
  • LCFY 44.93
  • Support Level
  • NURO $4.16
  • LCFY $7.05
  • Resistance Level
  • NURO $4.40
  • LCFY $8.00
  • Average True Range (ATR)
  • NURO 0.09
  • LCFY 0.62
  • MACD
  • NURO 0.03
  • LCFY -0.15
  • Stochastic Oscillator
  • NURO 95.24
  • LCFY 13.18

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.

Share on Social Networks: